A detailed history of Seven Mile Advisory transactions in Abb Vie Inc. stock. As of the latest transaction made, Seven Mile Advisory holds 2,153 shares of ABBV stock, worth $434,217. This represents 0.27% of its overall portfolio holdings.

Number of Shares
2,153
Previous 2,112 1.94%
Holding current value
$434,217
Previous $385 Million 3.98%
% of portfolio
0.27%
Previous 0.29%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 08, 2024

BUY
$154.79 - $180.76 $6,346 - $7,411
41 Added 1.94%
2,153 $369 Million
Q1 2024

May 08, 2024

BUY
$159.82 - $182.1 $18,379 - $20,941
115 Added 5.76%
2,112 $385 Million
Q4 2023

Feb 09, 2024

SELL
$137.6 - $154.97 $10,870 - $12,242
-79 Reduced 3.81%
1,997 $309 Million
Q3 2023

Nov 13, 2023

BUY
$133.59 - $154.65 $47,290 - $54,746
354 Added 20.56%
2,076 $309 Million
Q2 2023

Aug 08, 2023

BUY
$132.51 - $164.9 $228,182 - $283,957
1,722 New
1,722 $232 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $357B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Seven Mile Advisory Portfolio

Follow Seven Mile Advisory and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Seven Mile Advisory, based on Form 13F filings with the SEC.

News

Stay updated on Seven Mile Advisory with notifications on news.